The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study
Open accessAbstract
Objective: To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS). Methods: An inception cohort of patients with incident APS in 2000–2015 from a geographically well‐defined population was identified based on comprehensive individual medical records review. All cases met the 2006 Sydney criteria for APS (primary definition) or had a diagnosis of APS confirmed by physician consensus (secondary definition). Levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies, and anti–β2‐glycoprotein I antibodies were tested in a centralized laboratory. Incidence rates were age‐ and sex‐adjusted to the 2010 US white population. Prevalence estimates were obtained from the incidence rates, assuming that there was no increased mortality associated with APS and that migration in or out of the area was independent of disease status. Results: Among this cohort in 2000–2015, 33 cases of incident APS, as defined by the Sydney criteria, were identified (mean age of patients 54.2 years; 55% female, 97% white). The annual incidence of APS in adults ages ≥18 years was 2.1 (95% confidence interval [95% CI] 1.4–2.8) per 100,000 population. Incidence rates were similar in both sexes. The estimated prevalence of APS was 50 (95% CI 42–58) per 100,000 population, and was similar in both sexes. Six patients (18%) had a concurrent diagnosis of systemic lupus erythematosus. The most frequent clinical manifestation was deep vein thrombosis. The overall frequency of mortality among patients with APS was not significantly different from that in the general population (standardized mortality ratio 1.61, 95% CI 0.74–3.05). Conclusion: APS occurred in ~2 persons per 100,000 population per year. The estimated prevalence was 50 per 100,000 population. Overall mortality was not notably different from that observed in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974
Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007
Myasoedova, E., Crowson, C. S., Kremers, H. M., Therneau, T. M., & Gabriel, S. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27425 · Cited by 802
Self-citationSt. Sauver, J. L., Grossardt, B. R., Leibson, C. L., Yawn, B. P., Melton, L. J., & Rocca, W. A. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.11.009 · Cited by 651
St. Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., & Rocca, W. A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq482 · Cited by 649
Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system
St Sauver, J. L., Grossardt, B. R., Yawn, B. P., Melton, L. J., Pankratz, J. J., Brue, S. M., & Rocca, W. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys195 · Cited by 613
Andreoli, L., Chighizola, C. B., Banzato, A., Pons‐Estel, G. J., de Jesus, G. R., Erkan, D., & ACTION, O. B. O. A. (2013) · Arthritis Care & Research · doi:10.1002/acr.22066 · Cited by 363
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe
Cervera, R., Boffa, M.-C., Khamashta, M., & Hughes, G. (2009) · Lupus · doi:10.1177/0961203309106832 · Cited by 226
Corban, M. T., Duarte-Garcia, A., McBane, R. D., Matteson, E. L., Lerman, L. O., & Lerman, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.058 · Cited by 181
Self-citation
Cited by
Epidemiology and prevention of venous thromboembolism
Lutsey, P. L., & Zakai, N. A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00787-6 · Cited by 507
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
Knight, J. S., Branch, D. W., & Ortel, T. L. (2023) · BMJ · doi:10.1136/bmj-2021-069717 · Cited by 265
Sevim, E., Zisa, D., Andrade, D., Sciascia, S., Pengo, V., Tektonidou, M. G., Ugarte, A., Gerosa, M., Belmont, H. M., Zamorano, M. A. A., et al. (2022) · Arthritis Care & Research · doi:10.1002/acr.24468 · Cited by 88
Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances
Vandevelde, A., & Devreese, K. M. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082164 · Cited by 76
Ruffatti, A., Tonello, M., Calligaro, A., Del Ross, T., Favaro, M., Zen, M., Hoxha, A., & Alaibac, M. (2023) · Clinical Rheumatology · doi:10.1007/s10067-023-06699-1 · Cited by 9
Metadata
- Authors
- Duarte‐García, A., Pham, M. M., Crowson, C. S., Amin, S., Moder, K. G., Pruthi, R. K., Warrington, K. J., & Matteson, E. L.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2019-08
- Volume
- 71
- Issue
- 9
- Pages
- 1545-1552
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W2938707131
- Cited by
- 296
- References
- 17
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study. https://app.cochat.ai/papers/10.1002/art.40901
- The paper
- Duarte‐García, A., Pham, M. M., Crowson, C. S., Amin, S., Moder, K. G., Pruthi, R. K., Warrington, K. J., & Matteson, E. L. (2019). The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study. Arthritis & Rheumatology. https://doi.org/10.1002/art.40901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.